Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Health Network
Original Assignee
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health NetworkfiledCriticalUniversity Health Network
Priority claimed from CA2723320Aexternal-prioritypatent/CA2723320C/fr
Publication of CA3038531A1publicationCriticalpatent/CA3038531A1/fr
Compositions et procédés pour l'expression de récepteurs antigéniques chimériques anti-bcma ayant une il15 régulée par petites molécules dans des cellules t
Lymphocytes t car ciblant l'intégrine alphav bêta3 présentant des réponses antitumorales robustes contre les gliomes et d'autres tumeurs malignes solides